JMI Syringes & Medical Devices Limited (DSE: JMISMDL)
Bangladesh
· Delayed Price · Currency is BDT 129.40
+0.80 (0.62%)
At close: Oct 9, 2024
JMISMDL Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Revenue | 1,719 | 1,755 | 2,438 | 1,994 | 1,977 | 1,778 | Upgrade
|
| Revenue Growth (YoY) | -21.45% | -28.01% | 22.31% | 0.86% | 11.13% | 25.12% | Upgrade
|
| Cost of Revenue | 1,502 | 1,534 | 2,049 | 1,657 | 1,590 | 1,266 | Upgrade
|
| Gross Profit | 216.42 | 221.49 | 389.31 | 336.76 | 386.99 | 512.29 | Upgrade
|
| Selling, General & Admin | 147.16 | 149.64 | 176.37 | 150.89 | 158.44 | 185.09 | Upgrade
|
| Other Operating Expenses | 0.11 | - | - | - | 0 | 0.01 | Upgrade
|
| Operating Expenses | 147.87 | 150.24 | 176.97 | 151.29 | 180.05 | 185.1 | Upgrade
|
| Operating Income | 68.55 | 71.24 | 212.34 | 185.46 | 206.95 | 327.19 | Upgrade
|
| Interest Expense | -5.05 | -12.93 | -13.18 | -11.18 | -4.95 | -177.71 | Upgrade
|
| Interest & Investment Income | 0.3 | 1.53 | 6.89 | 10.4 | 12.41 | 0.15 | Upgrade
|
| Currency Exchange Gain (Loss) | -3.44 | - | -0.18 | 0.77 | 0.72 | -0.97 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.4 | 4.62 | 1.79 | 0.71 | 0.8 | 0.65 | Upgrade
|
| EBT Excluding Unusual Items | 62.76 | 64.46 | 207.67 | 186.17 | 215.93 | 149.31 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.05 | - | - | 0.26 | Upgrade
|
| Pretax Income | 62.76 | 64.46 | 207.72 | 186.17 | 215.93 | 149.57 | Upgrade
|
| Income Tax Expense | 230.13 | 214.43 | 107.12 | 97.06 | 119.89 | 83.02 | Upgrade
|
| Net Income | -167.37 | -149.96 | 100.6 | 89.11 | 96.04 | 66.55 | Upgrade
|
| Net Income to Common | -167.37 | -149.96 | 100.6 | 89.11 | 96.04 | 66.55 | Upgrade
|
| Net Income Growth | - | - | 12.89% | -7.22% | 44.30% | -11.85% | Upgrade
|
| Shares Outstanding (Basic) | 30 | 30 | 30 | 30 | 30 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 30 | 30 | 30 | 30 | 30 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | - | 100.91% | Upgrade
|
| EPS (Basic) | -5.57 | -4.99 | 3.35 | 2.96 | 3.20 | 2.21 | Upgrade
|
| EPS (Diluted) | -5.57 | -4.99 | 3.35 | 2.96 | 3.20 | 2.21 | Upgrade
|
| EPS Growth | - | - | 12.89% | -7.22% | 44.30% | -56.10% | Upgrade
|
| Free Cash Flow | 189.95 | 21.29 | -57.08 | 124.8 | -279.9 | 355.14 | Upgrade
|
| Free Cash Flow Per Share | 6.32 | 0.71 | -1.90 | 4.15 | -9.31 | 11.82 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | 3.600 | 2.206 | 2.206 | 2.206 | Upgrade
|
| Dividend Growth | -72.22% | -72.22% | 63.20% | 0% | 0% | 0% | Upgrade
|
| Gross Margin | 12.59% | 12.62% | 15.97% | 16.89% | 19.58% | 28.80% | Upgrade
|
| Operating Margin | 3.99% | 4.06% | 8.71% | 9.30% | 10.47% | 18.40% | Upgrade
|
| Profit Margin | -9.74% | -8.54% | 4.13% | 4.47% | 4.86% | 3.74% | Upgrade
|
| Free Cash Flow Margin | 11.05% | 1.21% | -2.34% | 6.26% | -14.16% | 19.97% | Upgrade
|
| EBITDA | 140.46 | 145.51 | 285.59 | 256.73 | 271.5 | 382.21 | Upgrade
|
| EBITDA Margin | 8.17% | 8.29% | 11.71% | 12.88% | 13.74% | 21.49% | Upgrade
|
| D&A For EBITDA | 71.92 | 74.27 | 73.24 | 71.27 | 64.55 | 55.02 | Upgrade
|
| EBIT | 68.55 | 71.24 | 212.34 | 185.46 | 206.95 | 327.19 | Upgrade
|
| EBIT Margin | 3.99% | 4.06% | 8.71% | 9.30% | 10.47% | 18.40% | Upgrade
|
| Effective Tax Rate | 366.69% | 332.63% | 51.57% | 52.14% | 55.52% | 55.50% | Upgrade
|
| Advertising Expenses | - | 9.1 | 12.47 | 6.04 | 0.41 | 0.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.